Published in Mol Ther on December 21, 2010
RD2-MolPack-Chim3, a packaging cell line for stable production of lentiviral vectors for anti-HIV gene therapy. Hum Gene Ther Methods (2013) 0.89
Preclinical safety and efficacy of an anti-HIV-1 lentiviral vector containing a short hairpin RNA to CCR5 and the C46 fusion inhibitor. Mol Ther Methods Clin Dev (2014) 0.85
Gene Therapy of the β-Hemoglobinopathies by Lentiviral Transfer of the β(A(T87Q))-Globin Gene. Hum Gene Ther (2016) 0.85
Development of a replication-competent lentivirus assay for dendritic cell-targeting lentiviral vectors. Mol Ther Methods Clin Dev (2015) 0.84
A Rev-Independent gag/pol Eliminates Detectable psi-gag Recombination in Lentiviral Vectors. Biores Open Access (2013) 0.83
Abrogated cryptic activation of lentiviral transfer vectors. Sci Rep (2012) 0.79
Visualization of cortical projection neurons with retrograde TET-off lentiviral vector. PLoS One (2012) 0.79
A tetracycline-regulated cell line produces high-titer lentiviral vectors that specifically target dendritic cells. J Vis Exp (2013) 0.79
False-positive HIV PCR test following ex vivo lentiviral gene transfer treatment of X-linked severe combined immunodeficiency vector. Mol Ther (2014) 0.78
Development of an equine-tropic replication-competent lentivirus assay for equine infectious anemia virus-based lentiviral vectors. Hum Gene Ther Methods (2012) 0.77
Transgenic sheep generated by lentiviral vectors: safety and integration analysis of surrogates and their offspring. Transgenic Res (2012) 0.76
Using Pulmozyme DNase treatment in lentiviral vector production. Hum Gene Ther Methods (2012) 0.75
High-level production of replication-defective human immunodeficiency type 1 virus vector particles using helper-dependent adenovirus vectors. Mol Ther Methods Clin Dev (2015) 0.75
Analysis of partial recombinants in lentiviral vector preparations. Hum Gene Ther Methods (2014) 0.75
Viral Vector-Mediated Antisense Therapy for Genetic Diseases. Genes (Basel) (2017) 0.75
Long-Term Safety Follow-Up of Subjects Previously Treated with Non-Replicating Retroviral Vector-Based Gene Therapies. Mol Diagn Ther (2016) 0.75
Detection of Replication Competent Lentivirus Using a qPCR Assay for VSV-G. Mol Ther Methods Clin Dev (2017) 0.75
In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science (1996) 28.95
LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science (2003) 19.77
Improved retroviral vectors for gene transfer and expression. Biotechniques (1989) 19.48
A third-generation lentivirus vector with a conditional packaging system. J Virol (1998) 16.07
Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1. Nat Med (2006) 9.68
Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges. Proc Natl Acad Sci U S A (1988) 9.35
Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J Virol (1998) 8.21
A safe packaging line for gene transfer: separating viral genes on two different plasmids. J Virol (1988) 7.87
Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus. J Virol (1991) 6.19
Construction and use of a safe and efficient amphotropic packaging cell line. Virology (1988) 5.58
Murine leukemia induced by retroviral gene marking. Science (2002) 3.59
RNA-based gene therapy for HIV with lentiviral vector-modified CD34(+) cells in patients undergoing transplantation for AIDS-related lymphoma. Sci Transl Med (2010) 3.53
Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector. J Virol (1997) 3.37
Production, concentration and titration of pseudotyped HIV-1-based lentiviral vectors. Nat Protoc (2009) 3.21
Titering lentiviral vectors: comparison of DNA, RNA and marker expression methods. Gene Ther (2002) 2.59
Efficacy and safety analyses of a recombinant human immunodeficiency virus type 1 derived vector system. Gene Ther (1999) 2.34
Genotoxicity of retroviral integration in hematopoietic cells. Mol Ther (2006) 2.34
Altering the tropism of lentiviral vectors through pseudotyping. Curr Gene Ther (2005) 2.21
Human endogenous retroviruses: nature, occurrence, and clinical implications in human disease. Clin Microbiol Rev (1996) 2.14
Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer. J Exp Med (1992) 2.12
Replication-defective chimeric helper proviruses and factors affecting generation of competent virus: expression of Moloney murine leukemia virus structural genes via the metallothionein promoter. Mol Cell Biol (1987) 1.94
Lentiviral vectors approach the clinic but fall back: National Institutes of Health Recombinant DNA Advisory Committee review of a first clinical protocol for use of a lentiviral vector. Mol Ther (2001) 1.71
Development of a high-titer retrovirus producer cell line capable of gene transfer into rhesus monkey hematopoietic stem cells. Proc Natl Acad Sci U S A (1990) 1.59
Development of a novel trans-lentiviral vector that affords predictable safety. Mol Ther (2000) 1.42
Targeted transduction patterns in the mouse brain by lentivirus vectors pseudotyped with VSV, Ebola, Mokola, LCMV, or MuLV envelope proteins. Mol Ther (2002) 1.39
Large-scale manufacture and characterization of a lentiviral vector produced for clinical ex vivo gene therapy application. Hum Gene Ther (2011) 1.37
Regulatory considerations for novel gene therapy products: a review of the process leading to the first clinical lentiviral vector. Hum Gene Ther (2005) 1.30
Supplemental guidance on testing for replication-competent retrovirus in retroviral vector-based gene therapy products and during follow-up of patients in clinical trials using retroviral vectors. Hum Gene Ther (2001) 1.28
Certification assays for HIV-1-based vectors: frequent passage of gag sequences without evidence of replication-competent viruses. Mol Ther (2003) 1.15
Analysis of retroviral packaging lines for generation of replication-competent virus. Virology (1990) 1.13
Evaluation of plasmid DNA removal from lentiviral vectors by benzonase treatment. Hum Gene Ther (2004) 1.12
Characterization of a replication-competent retrovirus resulting from recombination of packaging and vector sequences. Hum Gene Ther (1994) 1.11
Characterization and detection of artificial replication-competent lentivirus of altered host range. Mol Ther (2003) 1.09
Infection of human cells with murine amphotropic replication-competent retroviruses. Hum Gene Ther (1993) 1.08
Lentiviral vectors--the promise of gene therapy within reach? Science (1999) 1.07
Development of a sensitive assay for detection of replication-competent recombinant lentivirus in large-scale HIV-based vector preparations. Mol Ther (2003) 1.03
Production of lentiviral vectors by large-scale transient transfection of suspension cultures and affinity chromatography purification. Biotechnol Bioeng (2007) 1.02
Characterization of recombinant helper retroviruses from Moloney-based vectors in ecotropic and amphotropic packaging cell lines. Virology (1991) 0.93
Efficient gene transfer into the CNS by lentiviral vectors purified by anion exchange chromatography. Gene Ther (2002) 0.91
Novel bovine lentiviral vectors based on Jembrana disease virus. J Gene Med (2000) 0.90
Modified human immunodeficiency virus-based lentiviral vectors display decreased sensitivity to trans-dominant Rev. Hum Gene Ther (2000) 0.90
Lentivirus vector mobilization and spread by human immunodeficiency virus. Hum Gene Ther (2000) 0.89
Size-exclusion chromatography purification of high-titer vesicular stomatitis virus G glycoprotein-pseudotyped retrovectors for cell and gene therapy applications. Hum Gene Ther (2003) 0.85
Product-enhanced reverse transcriptase assay for replication-competent retrovirus and lentivirus detection. Hum Gene Ther (2005) 0.85
Characterization of recombination events leading to the production of an ecotropic replication-competent retrovirus in a GP+envAM12-derived producer cell line. Virology (2000) 0.82
A replication competent lentivirus (RCL) assay for equine infectious anaemia virus (EIAV)-based lentiviral vectors. Gene Ther (2006) 0.81
Lentiviral vectors: progress and potential. Curr Opin Mol Ther (2000) 0.80
Biosafety issues in lentivector production. Curr Top Microbiol Immunol (2002) 0.79
Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors. Gastroenterology (2007) 3.99
RNA-based gene therapy for HIV with lentiviral vector-modified CD34(+) cells in patients undergoing transplantation for AIDS-related lymphoma. Sci Transl Med (2010) 3.53
Mutations in SLC20A2 link familial idiopathic basal ganglia calcification with phosphate homeostasis. Nat Genet (2012) 3.34
Transplantation of adult mouse iPS cell-derived photoreceptor precursors restores retinal structure and function in degenerative mice. PLoS One (2011) 2.86
Gremlin is the BMP antagonist required for maintenance of Shh and Fgf signals during limb patterning. Nat Genet (2003) 2.31
The myeloid differentiation factor 88 (MyD88) is required for CD4+ T cell effector function in a murine model of inflammatory bowel disease. J Immunol (2008) 1.75
Uncoupling proton activation of vanilloid receptor TRPV1. J Neurosci (2007) 1.69
Retracted A genomic approach to colon cancer risk stratification yields biologic insights into therapeutic opportunities. Proc Natl Acad Sci U S A (2008) 1.69
A family of ductile intermetallic compounds. Nat Mater (2003) 1.66
Antihelminth compound niclosamide downregulates Wnt signaling and elicits antitumor responses in tumors with activating APC mutations. Cancer Res (2011) 1.58
Innate immune signaling by Toll-like receptor-4 (TLR4) shapes the inflammatory microenvironment in colitis-associated tumors. Inflamm Bowel Dis (2009) 1.53
ESG: extended similarity group method for automated protein function prediction. Bioinformatics (2009) 1.46
A decompositional approach to parameter estimation in pathway modeling: a case study of the Akt and MAPK pathways and their crosstalk. Bioinformatics (2006) 1.44
Neural stem cell-mediated enzyme/prodrug therapy for glioma: preclinical studies. Sci Transl Med (2013) 1.42
A novel Toll-like receptor 4 antagonist antibody ameliorates inflammation but impairs mucosal healing in murine colitis. Am J Physiol Gastrointest Liver Physiol (2009) 1.39
Age dependency of cartilage magnetic resonance imaging T2 relaxation times in asymptomatic women. Arthritis Rheum (2004) 1.28
The proline-rich homeodomain protein recruits members of the Groucho/Transducin-like enhancer of split protein family to co-repress transcription in hematopoietic cells. J Biol Chem (2004) 1.28
Safety and immunological efficacy of a prostate cancer plasmid DNA vaccine encoding prostatic acid phosphatase (PAP). Vaccine (2005) 1.23
Human T cell leukemia virus type I and neurologic disease: events in bone marrow, peripheral blood, and central nervous system during normal immune surveillance and neuroinflammation. J Cell Physiol (2002) 1.17
Lower socioeconomic status is associated with worse outcomes in pulmonary arterial hypertension. Am J Respir Crit Care Med (2012) 1.17
Stochastic roadmap simulation: an efficient representation and algorithm for analyzing molecular motion. J Comput Biol (2003) 1.15
Enhanced green fluorescent protein is a nearly ideal long-term expression tracer for hematopoietic stem cells, whereas DsRed-express fluorescent protein is not. Stem Cells (2006) 1.15
Scalable GMP compliant suspension culture system for human ES cells. Stem Cell Res (2012) 1.14
Gain-of-function mutations in SCN11A cause familial episodic pain. Am J Hum Genet (2013) 1.14
Oncogenic interaction between BCR-ABL and NUP98-HOXA9 demonstrated by the use of an in vitro purging culture system. Blood (2002) 1.11
Intratumoral epidermal growth factor receptor antisense DNA therapy in head and neck cancer: first human application and potential antitumor mechanisms. J Clin Oncol (2009) 1.04
Mutation in erythroid specific transcription factor KLF1 causes Hereditary Spherocytosis in the Nan hemolytic anemia mouse model. Genomics (2010) 1.04
Hysteresis of gating underlines sensitization of TRPV3 channels. J Gen Physiol (2011) 1.01
Laparoscopic or Lichtenstein repair for recurrent inguinal hernia: a meta-analysis of randomized controlled trials. ANZ J Surg (2012) 1.01
Pore turret of thermal TRP channels is not essential for temperature sensing. Proc Natl Acad Sci U S A (2010) 1.00
Hurdles to clinical translation of human induced pluripotent stem cells. J Clin Invest (2015) 0.98
Glycyrrhetinic acid-graft-hyaluronic acid conjugate as a carrier for synergistic targeted delivery of antitumor drugs. Int J Pharm (2012) 0.98
Regulation of Toll-like receptor 4-associated MD-2 in intestinal epithelial cells: a comprehensive analysis. Innate Immun (2009) 0.97
Proton inhibition of unitary currents of vanilloid receptors. J Gen Physiol (2009) 0.95
GMP scale-up and banking of pluripotent stem cells for cellular therapy applications. Methods Mol Biol (2011) 0.93
The role of prostaglandin E2 (PGE 2) in toll-like receptor 4 (TLR4)-mediated colitis-associated neoplasia. BMC Gastroenterol (2010) 0.93
Reaction time of the Continuous Performance Test is an endophenotypic marker for schizophrenia: a study of first-episode neuroleptic-naive schizophrenia, their non-psychotic first-degree relatives and healthy population controls. Schizophr Res (2006) 0.92
DRD2 polymorphisms modulate reward and emotion processing, dopamine neurotransmission and openness to experience. Cortex (2012) 0.92
A quantitative association study between schizotypal traits and COMT, PRODH and BDNF genes in a healthy Chinese population. Psychiatry Res (2007) 0.91
Teaching NeuroImages: methotrexate leukoencephalopathy mimicking a transient ischemic attack. Neurology (2010) 0.90
Optimal estimation of ion-channel kinetics from macroscopic currents. PLoS One (2012) 0.90
Using robotics to fold proteins and dock ligands. Bioinformatics (2002) 0.89
Wogonin reverses hypoxia resistance of human colon cancer HCT116 cells via downregulation of HIF-1α and glycolysis, by inhibiting PI3K/Akt signaling pathway. Mol Carcinog (2013) 0.89
Epigenetic stability, adaptability, and reversibility in human embryonic stem cells. Proc Natl Acad Sci U S A (2012) 0.89
Wogonin inhibits tumor angiogenesis via degradation of HIF-1α protein. Toxicol Appl Pharmacol (2013) 0.89
Methane emissions from free-ranging cattle: comparison of tracer and integrated horizontal flux techniques. J Environ Qual (2008) 0.88
Inter-α/β subunits coupling mediating pre-inactivation and augmented activation of BKCa(β2). Sci Rep (2013) 0.86
Interaction sites between the Slo1 pore and the NH2 terminus of the beta2 subunit, probed with a three-residue sensor. J Biol Chem (2007) 0.86
Optimizing dopaminergic differentiation of pluripotent stem cells for the manufacture of dopaminergic neurons for transplantation. Cytotherapy (2013) 0.86
Establishment of an HPLC identification system for detection of counterfeit steroidal drugs. J Pharm Biomed Anal (2007) 0.85
Using stochastic roadmap simulation to predict experimental quantities in protein folding kinetics: folding rates and phi-values. J Comput Biol (2007) 0.85
A computational and experimental study of the regulatory mechanisms of the complement system. PLoS Comput Biol (2011) 0.85
Product-enhanced reverse transcriptase assay for replication-competent retrovirus and lentivirus detection. Hum Gene Ther (2005) 0.85
Enhanced oral bioavailability of paclitaxel in pluronic/LHR mixed polymeric micelles: preparation, in vitro and in vivo evaluation. Eur J Pharm Sci (2012) 0.85
Oroxylin A reverses P-glycoprotein-mediated multidrug resistance of MCF7/ADR cells by G2/M arrest. Toxicol Lett (2013) 0.84
Computational models of protein kinematics and dynamics: beyond simulation. Annu Rev Anal Chem (Palo Alto Calif) (2012) 0.84
V8, a newly synthetic flavonoid, induces apoptosis through ROS-mediated ER stress pathway in hepatocellular carcinoma. Arch Toxicol (2013) 0.84
Effects of combined phacoemulsification and viscogoniosynechialysis versus trabeculectomy in patients with primary angle-closure glaucoma and coexisting cataract. Ophthalmologica (2012) 0.83
Efficient large volume lentiviral vector production using flow electroporation. Hum Gene Ther (2011) 0.83
Enhanced and sustained topical ocular delivery of cyclosporine A in thermosensitive hyaluronic acid-based in situ forming microgels. Int J Nanomedicine (2013) 0.83
Modest advances in survival for patients with colorectal-associated peritoneal carcinomatosis in the era of modern chemotherapy. J Surg Oncol (2012) 0.83
Bioinformatics resources for cancer research with an emphasis on gene function and structure prediction tools. Cancer Inform (2007) 0.83
Berberine analogue IMB-Y53 improves glucose-lowering efficacy by averting cellular efflux especially P-glycoprotein efflux. Metabolism (2012) 0.83
Effects of osteoprotegerin from transfection of pcDNA3.1(+)/chOPG on bioactivity of chicken osteoclasts. Acta Vet Scand (2011) 0.82
A novel donor splice-site mutation of major intrinsic protein gene associated with congenital cataract in a Chinese family. Mol Vis (2013) 0.82
Protein conformational flexibility analysis with noisy data. J Comput Biol (2008) 0.82
Characterization, epitope identification and mechanisms of the anti-septic capacity of monoclonal antibodies against macrophage migration inhibitory factor. Int Immunopharmacol (2011) 0.82
Surrogate markers of transport distance for out-of-hospital cardiac arrest patients. Prehosp Emerg Care (2011) 0.82
[Study on HPLC fingerprint of Tibetan herb Gymnadenia conopsea]. Zhong Yao Cai (2013) 0.81
A robust approach for the quantitation of viral concentration in an adenoviral vector-based human immunodeficiency virus vaccine by real-time quantitative polymerase chain reaction. Hum Gene Ther (2006) 0.81
Scalable pluripotent stem cell culture. Nat Biotechnol (2010) 0.81
TRPV1 channels are functionally coupled with BK(mSlo1) channels in rat dorsal root ganglion (DRG) neurons. PLoS One (2013) 0.81
Pharmacokinetics of a paclitaxel-loaded low molecular weight heparin-all-trans-retinoid acid conjugate ternary nanoparticulate drug delivery system. Biomaterials (2012) 0.81
Pluripotent stem cells for Parkinson's disease: progress and challenges. Stem Cell Res Ther (2013) 0.80
Markov dynamic models for long-timescale protein motion. Bioinformatics (2010) 0.80
Production of CGMP-Grade Lentiviral Vectors. Bioprocess Int (2012) 0.79
Oroxylin A reverses CAM-DR of HepG2 cells by suppressing Integrinβ1 and its related pathway. Toxicol Appl Pharmacol (2012) 0.79
Oroxylin A inhibits hypoxia-induced invasion and migration of MCF-7 cells by suppressing the Notch pathway. Anticancer Drugs (2014) 0.78
All 4 bile salt hydrolase proteins are responsible for the hydrolysis activity in Lactobacillus plantarum ST-III. J Food Sci (2012) 0.78
Regulatory considerations for the development of autologous induced pluripotent stem cell therapies. Regen Med (2010) 0.78
Thermal inactivation of adenovirus type 5. J Virol Methods (2004) 0.78
Bacterial artificial chromosomes (BACs)-on-Beads™ as a diagnostic platform for the rapid aneuploidy screening of products of conception. Mol Med Rep (2013) 0.78
Enhanced 5-fluorouracil cytotoxicity in high COX-2 expressing hepatocellular carcinoma cells by wogonin via the PI3K/Akt pathway. Biochem Cell Biol (2013) 0.78
Retraction for Garman et al: A genomic approach to colon cancer risk stratification yields biologic insights into therapeutic opportunities. Proc Natl Acad Sci U S A (2011) 0.78
Oroxylin A improves the sensitivity of HT-29 human colon cancer cells to 5-FU through modulation of the COX-2 signaling pathway. Biochem Cell Biol (2012) 0.78
Electrical switching of DNA monolayers investigated by surface plasmon resonance. Langmuir (2006) 0.78
Cell therapy product administration and safety: data capture and analysis from the Production Assistance for Cellular Therapies (PACT) program. Transfusion (2014) 0.77
Material basis for inhibition of dragon's blood on capsaicin-induced TRPV1 receptor currents in rat dorsal root ganglion neurons. Eur J Pharmacol (2013) 0.77
Ternary complexes with core-shell bilayer for double level targeted gene delivery: in vitro and in vivo evaluation. Pharm Res (2012) 0.77
Accumulation and resistance to copper of two biotypes of Cynodon dactylon. Bull Environ Contam Toxicol (2009) 0.77
Recombinant expressions of sweet plant protein mabinlin II in Escherichia coli and food-grade Lactococcus lactis. World J Microbiol Biotechnol (2015) 0.77
The role of Nrf2 and apoptotic signaling pathways in oroxylin A-mediated responses in HCT-116 colorectal adenocarcinoma cells and xenograft tumors. Anticancer Drugs (2012) 0.77
[In situ repair of parastomal hernia with Sublay methods in 34 cases]. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi (2010) 0.76
Biological and biochemical characterization of a red-eye mutant in Nilaparvata lugens (Hemiptera: Delphacidae). Insect Sci (2013) 0.76
[Impact of Cu and Zn pollution on rape growth and soil enzyme activity]. Ying Yong Sheng Tai Xue Bao (2007) 0.76